BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoffmann-Vold AM, Distler O, Crestani B, Antoniou KM. Recent advances in the management of systemic sclerosis-associated interstitial lung disease. Curr Opin Pulm Med 2022. [PMID: 35855572 DOI: 10.1097/MCP.0000000000000901] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Manfredi A, Salvarani C, Sebastiani M. Rituximab for connective tissue disease-associated interstitial lung disease. Lancet Respir Med 2023;11:3-4. [PMID: 36375480 DOI: 10.1016/S2213-2600(22)00356-3] [Reference Citation Analysis]
2 Sarbu A, Maurer B. Die interstitielle Lungenerkrankung bei systemischer Sklerose. Arthritis und Rheuma 2022;42:330-336. [DOI: 10.1055/a-1893-4920] [Reference Citation Analysis]
3 Herrick AL, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK, NIHR Manchester Biomedical Research Centre, Manchester, UK. Advances in the Treatment of Systemic Sclerosis. Rheumatology 2022;1:61. [DOI: 10.17925/rmd.2022.1.2.61] [Reference Citation Analysis]